International group calls for end to selective reporting of clinical trials
Free access to all data will provide the best care for patients, says Cochrane Collaboration. People don’t like to reveal their failures. But when it comes to clinical trials, researchers should be compelled to make even their negative results public, according to a statement issued by an international group that reviews medical research studies. The release of all information and data from randomized clinical trials would allow physicians to provide the best possible care for patients, says the Cochrane Collaboration. In 2004, the pharmaceutical company Merck withdrew its blockbuster arthritis drug rofecoxib (Vioxx) from pharmacies around the world because of an increased risk … Read more…